APA (7th ed.) Citation

Peng, L., Jiang, Y., Chen, H., Wang, Y., Lan, Q., Chen, S., . . . Yin, D. (2024). Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma. Acta pharmaceutica Sinica. B, 14(5), 2119-2136. https://doi.org/10.1016/j.apsb.2024.02.025

Chicago Style (17th ed.) Citation

Peng, Li, et al. "Transcription Factor EHF Interacting with Coactivator AJUBA Aggravates Malignancy and Acts as a Therapeutic Target for Gastroesophageal Adenocarcinoma." Acta Pharmaceutica Sinica. B 14, no. 5 (2024): 2119-2136. https://doi.org/10.1016/j.apsb.2024.02.025.

MLA (9th ed.) Citation

Peng, Li, et al. "Transcription Factor EHF Interacting with Coactivator AJUBA Aggravates Malignancy and Acts as a Therapeutic Target for Gastroesophageal Adenocarcinoma." Acta Pharmaceutica Sinica. B, vol. 14, no. 5, 2024, pp. 2119-2136, https://doi.org/10.1016/j.apsb.2024.02.025.